the efficacy of dexmedetomidinethe for myocardial protection and postoperative outcome during elderly thoracic surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-17010612

Enrollment

Unknown

Registered

2017-02-12

Start date

2017-02-13

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

dex group:use dexmedetomidine during surgey

Control group:not use dexmedetomidine during surgey

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Inclusion criteria

Inclusion criteria: Age>=65 years, selective pulmonary lobectomy

Exclusion criteria

Exclusion criteria: severe valvular heart disease, ischamic heart disease, congestive heart failure, cardiac arrhythmias, liver and kidney dysfunction, cerabrovascular diseases within 6 months or with neurological sequelae, diabetes with perapheral vascular complications, blood creatinine >2.0mg/dl

Design outcomes

Primary

Measure	Time frame
TnI;	—

Countries

China

Contacts

Public ContactWang Tianlong

Department of anesthesiology, Capital Medical University, Xuanwu Hospital, Beijing, China

w_tl9959@hotmail.com+86 13910525304

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026